2 completed, 2 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
Follow Autosomal Dominant Polycystic Kidney: new trials by email Literature Review of Autosomal Dominant Polycystic Kidney trials Research Report on Autosomal Dominant Polycystic Kidney
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glucagon-Like Peptide-1 Receptor Agonist in ADPKD Tirzepatide, Placebo - Autosomal Dominant Polycystic Kidney, Obesity | Phase 2 | Recruiting | University of Colorado, Denver | 126 | 2025-03-06 | 2025-05-06 |
| A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease Leuprorelin - Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney | Phase 2 | Recruiting | University Medical Center Groningen | 36 | 2022-06-01 | 2022-11-04 |
| A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX Bardoxolone methyl capsules - IgA Nephropathy, CKD Associated With Type 1 Diabetes | Phase 2 | Completed | Biogen | 103 | 2017-12-26 | 2025-06-03 |
| Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD Tesevatinib, Placebo - Autosomal Dominant Polycystic Kidney, ADPKD | Phase 2 | Completed | Kadmon, a Sanofi Company | 80 | 2017-10-12 | 2023-02-06 |
Polycystic Kidney, Autosomal Dominant (4) · Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1) · Obesity (1) · Polycystic Kidney Diseases (1) · Polycystic liver disease (1)
Abnormalities, Multiple (4) · Ciliopathies (4) · Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genetic Diseases, Inborn (4) · Kidney Diseases (4) · Kidney Diseases, Cystic (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Polycystic Kidney Diseases (3) · Autoimmune Diseases (1) · Body Weight (1)
Leuprolide (1) · Tirzepatide (1) · XL647 (1) · bardoxolone methyl (1)
Biogen (1) · Kadmon, a Sanofi Company (1) · University Medical Center Groningen (1) · University of Colorado, Denver (1)
United States (3) · Netherlands (1)
R01DK138915 (1)